Q & M Dental Group (Singapore) (QC7) Corporate presentation summary

Regional presence and expansion

• Operates 114 clinics in Singapore, 36 in Malaysia, 33 in Thailand, 39 in Australia, and 11 in China, including 4 hospitals.

• Holds approximately 10% market share in Singapore and is listed on SGX with a market cap of $527.9 million SGD as of July 2026.

• Pursuing strategic acquisitions in Australia (100%), Thailand (51%), and China to strengthen its Asia-Pacific footprint.

Financial performance and projections

• Revenue projected to grow from $197m in FY2025 to $425m by Year 5, a 2.2x increase.

• PATMI expected to rise from $13.9m to $45.8m, a 3.3x uplift over five years.

• EBITDA forecasted to increase from $42.4m to $120.5m, a 2.8x growth.

• EPS projected to nearly triple from 1.47c to 4.11c, despite share base expansion.

Acquisition highlights and impact

• Australia acquisition valued at AUD 150M (SGD 134.5M), Thailand at THB 994.5M (SGD 38.4M).

• Acquisitions structured with cash, share capital injection, and consideration shares, including long-term vendor alignment and profit guarantees.

• Australia is the largest single acquisition, contributing $42.4m revenue and $9.4m PATMI in Year 1.

• Thailand acquisition is the fastest-growing, with revenue more than doubling over five years.